Clinical Trials
2 trialsNCT00861419 2017-02-08
To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.
Amgen
Phase 1 Completed
NCT01386866 2011-07-15
Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors
Amgen
Phase 1 Completed